Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
H. Marshall, R. Carter, M. Torbey, S. Minion, C. Tolson, H. Sidjabat, R. Thomson (Brisbane, Australia). Clinical significance of Mycobacterium lentiflavum – An emerging pathogen found in potable water. Eur Respir J 2010; 36: Suppl. 54, 3086

Member's Comments

No comment yet.

Related content which might interest you: The results of drug resistance survey of MDR-strains on second line drugs obtains in national reference laboratory – " M.Nasta " Institute – Bucharest Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2011 Documentation & accuracy of smoking status – An educational need? Source: Annual Congress 2011 - Smoking cessation science and smoking-related disorders Year: 2011 Usability evaluation of NEXThaler® versus Diskus® and Turbuhaler® Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012 Tuberculosis – is there anything different over a decade? Source: Annual Congress 2009 - Socio-economic impact of tuberculosis Year: 2009 Drug interaction in tuberculosis treatment – The role of pharmacists Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012 Optimization of inhalation treatment – Evaluation of influence of PNEUMOlogic® and Optimiser® spacers on aerosol particle distribution from pMDI-EB Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I Year: 2011 Airway resistances: Raw, sRaw, sReff – Which is the best determinant of airway function? Source: Annual Congress 2010 - Lung function from infancy to adulthood Year: 2010 Nutritional risk screening 2002 – Application in pneumology Source: Annual Congress 2012 - New insights in the clinical management of lung diseases Year: 2012 T spot TB reactivity – ²to treat or not to treat² Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009 Tackling tuberculosis among hard to reach groups in London – The Find&Treat experience Source: Annual Congress 2010 - Tuberculosis control Year: 2010 Clinical pattern of extrapulmonary tuberculosis (EPT) as observed at a teaching hospital in India – are we missing them? Source: Annual Congress 2009 - Pulmonary infections Year: 2009 Clinical decision making in alpha1 antitrypsin deficiency emphysema – Methodologies to determine individual rates of FEV1 decline Source: Annual Congress 2010 - Novel biomarkers and old parameters in approaching pulmonary diseases Year: 2010 Diving; does it matter, pO2 or FIO2? Source: Annual Congress 2010 - Advances in lung function I Year: 2010 Homefill II oxygen concentrator system – ²better for your patient and your pocket² Source: Annual Congress 2009 - Oxygen, end-of-life and care for chronic respiratory patients Year: 2009 Clinical evaluation in 14 cases of diffuse alveolar hemorrhage – Relationship between initial findings and prognosis – Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 EGFR – a useful biomarker? Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Over-reading spirometry – Man or machine? Source: Annual Congress 2011 - Quality control in lung function and exercise-related issues Year: 2011 Reorganisation of the tuberculosis laboratory network in Serbia – the lesson we learned Source: Annual Congress 2009 - Tuberculosis control Year: 2009 The emerging problem of treating pulmonary M. avium complex (MAC) disease – microbial substitution of MAC to M. abscessus, Scedosporium and Nocardia after multi-drug chemotherapy in pulmonary MAC disease Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections Year: 2009 Triple 0 – A new respiratory syndrome? Source: Annual Congress 2012 - Advanced experience with long-term noninvasive ventilation and late-breaking abstracts Year: 2012